Daiichi Sankyo
$25.199876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$25.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.58 (-2.23%) As of 11:16 AM EDT today
Why Robinhood?
You can buy or sell Daiichi Sankyo and other stocks, options, and ETFs commission-free!
About DSNKY
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. Read More The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan. DSNKY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com). The listed name for DSNKY is Daiichi Sankyo Co Limited Sponsored ADR (Japan).
CEO
Employees
15,348
Headquarters
Tokyo, Tokyo
Founded
2005
Market Cap
146.95B
Price-Earnings Ratio
137.04
Dividend Yield
—
Average Volume
30.36K
High Today
$25.26
Low Today
$25.19
Open Price
$25.26
Volume
14.30K
52 Week High
$33.21
52 Week Low
$16.11